Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Gentoo Media - Stable quarter despite sports margin headwind

21 maj 2026

<a id="bm-comp-0f574480-d96b-4e01-bd32-d870eb8ad00b" name="bm-comp-0f574480-d96b-4e01-bd32-d870eb8ad00b" class="BMCustomAnchor"></a><table><tr><td bm-component-id="0f574480-d96b-4e01-bd32-d870eb8ad00b" style="vertical-align: top; width:100.000000%;"><ul><li>Q1 adj. EBITDA in line with FactSet consensus</li><li>Expect limited consensus estimate revisions</li><li>Value of deposits stable around EUR 200m</li></ul></td></tr></table><a id="bm-comp-181f3dba-32e4-423a-affb-74426e09a015" name="bm-comp-181f3dba-32e4-423a-affb-74426e09a015" class="BMCustomAnchor"></a><table><tr><td bm-component-id="181f3dba-32e4-423a-affb-74426e09a015" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3"><strong>Q1 outcome</strong></h3><p>Gentoo reported Q1 sales of EUR 24.0m, corresponding to a 5% y-o-y decline, in line with both ABGSCe and Factset consensus. Moreover, adj. EBITDA of EUR 10.5m was 6% below ABGSCe but in line with consensus. The sports margin was soft during February, in line with commentary from both Better Collective and various operators. That said, player deposit volumes continue to be stable around EUR 200m, suggesting that the underlying trend is stable despite quarterly fluctuations in the sports margin.</p><h3 class="bm-h3">No changes to guidance</h3><p>The Q1 report was unsurprising, and Gentoo has therefore maintained its guidance ('26e revenue of EUR 105-115m, adj. EBITDA of EUR 49-54m and operating cash flow of EUR 37-41m). Operating cash flow was roughly EUR 7m, up approx. 60% y-o-y, de-risking the cash flow guidance a bit. This is encouraging to see given Gentoo's leverage ratio of close to 2.7x LTM EBITDA (down 0.2x sequentially).</p><h3 class="bm-h3">Mechanical estimate revisions flat</h3><p>The Gentoo share is down 4% YTD, compared to OMXSGI, which is up 6% YTD. Based on our unrevised estimates, Gentoo is trading at 3.4x '26e EV/EBITDA. Following the report, which was in line with consensus' expectations, we anticipate consensus to maintain its revenue and EBITDA estimates. More details are likely to be presented on the conference call at 10.00 CET. Link to the webcast <a data-bm-trackable="false" href="https://www.redeye.se/events/1144484/live-q-gentoo-media-6" target="_blank">here</a>.</p></td></tr></table><a id="bm-comp-7c6e5e06-23e8-43d8-91ae-58f7c5146383" name="bm-comp-7c6e5e06-23e8-43d8-91ae-58f7c5146383" class="BMCustomAnchor"></a><table><tr><td bm-component-id="7c6e5e06-23e8-43d8-91ae-58f7c5146383" style="vertical-align: top; width:100.000000%;"><table id="bm-img-549b9407-83b7-46e1-ac10-2a17a021df68" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="549b9407-83b7-46e1-ac10-2a17a021df68" bm-img-original-height="424" bm-img-original-width="972" bm-img-svg="image:image_upload/96412_f6108811-bfad-4a99-94d6-0feae5f9b23f.svg" bm-img-width-hint="100%" id="bm-id-549b9407-83b7-46e1-ac10-2a17a021df68" src="https://abgsc.bluematrix.com/images/image_upload/96412_f6108811-bfad-4a99-94d6-0feae5f9b23f_727.png" svg="/nas/web/clients/abgsc/images/image_upload/96412_f6108811-bfad-4a99-94d6-0feae5f9b23f.svg" width="727" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, Company data, FactSet.</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys
2026-07-05 StrongPoint - Steady through the transition StrongPoint Analys
2026-07-03 Ascelia Pharma - Complete Response Letter for Orv... Ascelia Pharma Analys
2026-07-03 Fastpartner - Positive development on IFPM guidan... Fastpartner Analys